Canadian Import Growth Outpaces U.S. Rx Market In 2004, IMS Data Show
Canadian imports are still gaining share in the U.S. market despite the launch of multiple discount programs for seniors and other uninsured consumers, IMS Health data indicate
You may also be interested in...
The Commerce Department does not view free trade agreements as an effective tool to change international pharmaceutical price controls
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials